Creutzfeldt-Jakob disease with neuroleptic malignant syndrome

Julija Čiauškaitė; Ieva Puleikytė; Simonas Jesmanas; Giedrė Jurkevičienė; Antanas Vaitkus; Daiva Rastenytė

doi:10.1002/ccr3.4699

Creutzfeldt-Jakob disease with neuroleptic malignant syndrome

Clin Case Rep. 2021 Aug 24;9(8):e04699. doi: 10.1002/ccr3.4699. eCollection 2021 Aug.

Authors

Julija Čiauškaitė¹, Ieva Puleikytė¹, Simonas Jesmanas², Giedrė Jurkevičienė¹, Antanas Vaitkus¹, Daiva Rastenytė¹

Affiliations

¹ Department of Neurology Medical Academy Lithuanian University of Health Sciences Kaunas Lithuania.
² Department of Radiology Medical Academy Lithuanian University of Health Sciences Kaunas Lithuania.

Abstract

Creutzfeldt‐Jakob disease (CJD) is a rare rapidly progressive fatal neurodegenerative disease. Neuroleptic malignant syndrome (NMS) is a complication of antipsychotic medications which may be used to treat neuropsychiatric symptoms of CJD. We present a case of a 51‐year‐ old woman with CJD who developed NMS after being prescribed quetiapine.

Keywords: Creutzfeldt‐Jakob disease; atypical antipsychotic medications; electroencephalography; magnetic resonance imaging; neuroleptic malignant syndrome; quetiapine.

Publication types

Case Reports